Acadia Pharmaceuticals Inc (ACAD) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Acadia Pharmaceuticals Inc   (NASDAQ: ACAD)
 

Acadia Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Acadia Pharmaceuticals Inc inventory turnover ratio, the Acadia Pharmaceuticals Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.06 in the first quarter 2026, yet the ratio remained below the average, as ACAD's market remain challenging.Average inventory processing period, for the Acadia Pharmaceuticals Inc in Mar 31 2026 quarter, has decreased to 344 days, compare to 361 days, in the Dec 31 2025 quarter.

Within Healthcare sector 308 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the fourth quarter 2025, to 1434.

ACAD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Acadia Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACAD Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 0.87 % 21.47 % 199.19 % 480.32 % 1600.13 %
Y / Y Cost of Sales Growth 21.57 % 20.28 % 14.8 % 13.74 % -11.15 %
Inventory Turnover Ratio (TTM) 1.06 1.01 1.02 1.16 1.5
ACAD's Total Ranking # 1434 # 0 # 683 # 1006 # 1005
Average inventory processing period 345 362 359 314 244
Seq. Inventory Growth -27.52 % 44.85 % -8.9 % 5.47 % -12.72 %
Seq. Cost of Sales Growth -5.47 % 21.15 % 4.4 % 1.68 % -6.47 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 89
Healthcare Sector # 309
Overall Market # 1434

Inventory Turnover Ratio Statistics
High Average Low
13.33 2.75 0.95
(Mar 31 2024)   (Jun 30 2021)



ACAD Company Profile >> Back to ACAD Efficiency Comparisons >> Compare ACAD Inventory Turnover Ratio to its Competitors

Financial Statements
Acadia Pharmaceuticals Inc 's Inventories $ 81 Millions Visit ACAD's Balance sheet
Acadia Pharmaceuticals Inc 's Cost of Revenues TTM $ 93 Millions Visit ACAD's Income Statement
What are ACAD's Sales? Visit ACAD's Sales by Segment

Other Inventory Turnover Ratios
Acadia Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ACAD's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ACAD's Competitors
Inventory Turnover Ratio for ACAD's Suppliers
Inventory Turnover Ratio for ACAD's Customers

You may also want to know
ACAD's Sales Growth Rates ACAD's Pe Price to earnings ratio ACAD's Receivables Turnover Ratio ACAD's Stock Quote
ACAD's Net Income Growth Rates ACAD's Ps Price to Sales ratio ACAD's Sales per Employee ACAD's Asset Turnover Ratio
ACAD's Net Margin ACAD's Pb Price to Book ratio ACAD's Financial Strength Ratios ACAD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Iovance Biotherapeutics inc   3.14 $ 165.941  Millions$ 53  Millions
Lftd Partners Inc   3.12 $ 28.258  Millions$ 9  Millions
Prestige Consumer Healthcare Inc   3.11 $ 493.000  Millions$ 159  Millions
Beyond Air Inc   3.07 $ 6.521  Millions$ 2  Millions
Bausch Health Companies Inc   3.07 $ 2,987.000  Millions$ 974  Millions
Indivior Pharmaceuticals Inc   3.03 $ 242.000  Millions$ 80  Millions
Amneal Pharmaceuticals Inc   3.02 $ 1,868.000  Millions$ 618  Millions
Logicmark Inc  3.01 $ 3.826  Millions$ 1  Millions
Mettler toledo International Inc   3.01 $ 1,189.678  Millions$ 395  Millions
Revvity Inc  3.00 $ 1,151.379  Millions$ 384  Millions
Cannapharmarx Inc   2.98 $ 2.921  Millions$ 1  Millions
Becton Dickinson And Company  2.97 $ 11,368.000  Millions$ 3,821  Millions
Dexcom Inc   2.97 $ 1,854.000  Millions$ 624  Millions
Msa Safety Inc  2.93 $ 1,020.000  Millions$ 349  Millions
Nexgel Inc   2.92 $ 6.000  Millions$ 2  Millions
Abbott Laboratories  2.91 $ 19,741.000  Millions$ 6,785  Millions
Zai Lab Limited  2.91 $ 128.112  Millions$ 44  Millions
Mimedx Group Inc   2.87 $ 74.000  Millions$ 26  Millions
Dentsply Sirona Inc   2.82 $ 1,880.000  Millions$ 666  Millions
Catalyst Pharmaceuticals Inc   2.82 $ 83.817  Millions$ 30  Millions
Evofem Biosciences Inc   2.82 $ 4.662  Millions$ 2  Millions
Livanova Plc  2.80 $ 464.684  Millions$ 166  Millions
Orthofix Medical Inc   2.79 $ 242.580  Millions$ 87  Millions
Lifecore Biomedical Inc   2.76 $ 89.000  Millions$ 32  Millions
Zeo Scientifix Inc   2.76 $ 1.291  Millions$ 0  Millions
Akebia Therapeutics Inc   2.76 $ 44.127  Millions$ 16  Millions
Biomerica Inc   2.72 $ 4.142  Millions$ 2  Millions
Nephros Inc   2.71 $ 8.000  Millions$ 3  Millions
Neogen Corporation  2.70 $ 478.000  Millions$ 177  Millions
Merck and Co Inc   2.62 $ 17,158.000  Millions$ 6,546  Millions

Date modified: 2026-06-22T14:32:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.